|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.684
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.490
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.462
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.428
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.404
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.381
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.368
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.354
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.325
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.304
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.290
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.280
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.212
|
Human |
|
|
neural tube development
|
GO:0021915 |
160 |
0.212
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.200
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.178
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.175
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.162
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.161
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.161
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.159
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.157
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.157
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.152
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.149
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.147
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.147
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.145
|
|
|
|
cerebellar granule cell precursor tangential migration
|
GO:0021935 |
1 |
0.138
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.138
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.137
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.133
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.130
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.129
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.123
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.121
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.118
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.116
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.115
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.104
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.103
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.103
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.102
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.102
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.101
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.098
|
|
|
|
rhombomere formation
|
GO:0021594 |
1 |
0.098
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.096
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.096
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.096
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.094
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.092
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.086
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.085
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.085
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.085
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.084
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.083
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.079
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.079
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.078
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.075
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.074
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.074
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.073
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.073
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.071
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.071
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.070
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.070
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.070
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.069
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.069
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.069
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.067
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.065
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.065
|
Human |
|
|
axonogenesis
|
GO:0007409 |
274 |
0.064
|
|
|
|
neuroblast fate determination
|
GO:0007400 |
1 |
0.064
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.064
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.064
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.063
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.063
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.063
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.063
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.062
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.062
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.061
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.061
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.061
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.061
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.059
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.059
|
|
|
|
compartment pattern specification
|
GO:0007386 |
4 |
0.057
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.056
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.056
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.055
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.055
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.054
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.054
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.054
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.053
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.053
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.052
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.051
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.051
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.051
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.051
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.051
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.050
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.049
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.049
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.049
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.049
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.049
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.048
|
|
|
|
heart valve morphogenesis
|
GO:0003179 |
21 |
0.048
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.048
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.048
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.048
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.046
|
|
|
|
planar cell polarity pathway involved in neural tube closure
|
GO:0090179 |
14 |
0.046
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.045
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.045
|
|
|
|
basal protein localization
|
GO:0045175 |
1 |
0.045
|
|
|
|
positive regulation of notch signaling pathway
|
GO:0045747 |
18 |
0.045
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.045
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.045
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.044
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.044
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.044
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.044
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.044
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.044
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.044
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.044
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.043
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.042
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.042
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.042
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.042
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.042
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.042
|
|
|
|
neurohypophysis development
|
GO:0021985 |
2 |
0.042
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.041
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.041
|
|
|
|
negative regulation of dendritic spine development
|
GO:0061000 |
3 |
0.041
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.041
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.041
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.041
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.041
|
|
|
|
regulation of mammary gland epithelial cell proliferation
|
GO:0033599 |
12 |
0.040
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.040
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.040
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.040
|
|
|
|
stem cell division
|
GO:0017145 |
30 |
0.040
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.040
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.039
|
|
|
|
vagus nerve morphogenesis
|
GO:0021644 |
2 |
0.039
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.039
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.039
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.039
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.039
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.039
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.039
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.039
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.038
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.038
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.038
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.038
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.037
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.037
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.037
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.037
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.037
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.037
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.037
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.036
|
|
|
|
fourth ventricle development
|
GO:0021592 |
2 |
0.036
|
|
|
|
mammary gland lobule development
|
GO:0061377 |
22 |
0.036
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.036
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.036
|
|
|
|
regulation of store operated calcium entry
|
GO:2001256 |
4 |
0.036
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.035
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.035
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.035
|
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.034
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.034
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.034
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.034
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.034
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.034
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.034
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.034
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.034
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.034
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.033
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.033
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.033
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.033
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.033
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.033
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.033
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.032
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.032
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.032
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.032
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.032
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.032
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.032
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.032
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.032
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.032
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.032
|
|
|
|
regulation of dna binding
|
GO:0051101 |
39 |
0.031
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.031
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.031
|
Human |
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.030
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.030
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.030
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.030
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.030
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.030
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.030
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.029
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.029
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.029
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.029
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.029
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.029
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.029
|
|
|
|
regulation of establishment of planar polarity involved in neural tube closure
|
GO:0090178 |
15 |
0.029
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.028
|
Human |
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.028
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.028
|
|
|
|
store operated calcium entry
|
GO:0002115 |
7 |
0.028
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.028
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.028
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.028
|
Human |
|
|
gene silencing
|
GO:0016458 |
38 |
0.028
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.027
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.027
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.027
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.027
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.027
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.027
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.027
|
|
|
|
ectodermal cell differentiation
|
GO:0010668 |
3 |
0.027
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.027
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.027
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.027
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.027
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.027
|
|
|
|
dna templated transcription termination
|
GO:0006353 |
4 |
0.027
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.027
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.027
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.027
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.027
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.027
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.027
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.026
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.026
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.026
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.026
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.026
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.026
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.026
|
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.026
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.026
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.025
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.025
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.025
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.025
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.025
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.025
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.025
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.024
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.024
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.024
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.024
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.024
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.024
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.024
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.024
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.024
|
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.024
|
|
|
|
regulation of ureteric bud formation
|
GO:0072106 |
3 |
0.024
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.024
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.024
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.024
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.024
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.024
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.023
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.023
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.023
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.023
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.023
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.023
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.023
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.023
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.023
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.023
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.023
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.023
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.023
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.022
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.022
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.022
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
22 |
0.022
|
|
|
|
somatic stem cell division
|
GO:0048103 |
19 |
0.022
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.022
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.022
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.022
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.022
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.022
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.022
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.022
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.021
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.021
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.021
|
|
|
|
positive regulation of lymphocyte apoptotic process
|
GO:0070230 |
13 |
0.021
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.021
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.021
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.021
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.021
|
|
|
|
negative regulation of calcium ion dependent exocytosis
|
GO:0045955 |
3 |
0.021
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
23 |
0.021
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.021
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.021
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.021
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.021
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.020
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.020
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.020
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.020
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.020
|
|
|
|
mammary gland alveolus development
|
GO:0060749 |
22 |
0.020
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.020
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.020
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.020
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.020
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.020
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.020
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.020
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.020
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.020
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.020
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.020
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.020
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.020
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.020
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.020
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.020
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.020
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.020
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.020
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.019
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.019
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.019
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.019
|
|
|
|
cell migration involved in endocardial cushion formation
|
GO:0003273 |
3 |
0.019
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.019
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.019
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.019
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.019
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.019
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.019
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.019
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.019
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.019
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.019
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.019
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.019
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.019
|
|
|
|
chemorepulsion of branchiomotor axon
|
GO:0021793 |
1 |
0.019
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.019
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.018
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.018
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.018
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.018
|
|
|
|
circadian behavior
|
GO:0048512 |
13 |
0.018
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.018
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.018
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.018
|
|
|
|
cochlea morphogenesis
|
GO:0090103 |
22 |
0.018
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.018
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.018
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.018
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.018
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.018
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.018
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.018
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.018
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.018
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.018
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.018
|
|
|
|
negative regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010642 |
7 |
0.018
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.018
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.018
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.018
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.017
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.017
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.017
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.017
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.017
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.017
|
|
|
|
negative regulation of dendritic spine morphogenesis
|
GO:0061002 |
3 |
0.017
|
|
|
|
rhythmic behavior
|
GO:0007622 |
15 |
0.017
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.017
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.017
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.017
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.017
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.017
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.017
|
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.017
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.017
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.017
|
|
|
|
cell migration involved in metanephros development
|
GO:0035788 |
2 |
0.017
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.017
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.017
|
|
|
|
cell cell signaling involved in mammary gland development
|
GO:0060764 |
2 |
0.016
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.016
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.016
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.016
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.016
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.016
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.016
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.016
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.016
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.016
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.016
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.016
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.016
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.016
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.016
|
|
|
|
negative regulation of cell size
|
GO:0045792 |
3 |
0.016
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.015
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.015
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.015
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.015
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.015
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.015
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.015
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.015
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.015
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.015
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.015
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.015
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.015
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.015
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.015
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.015
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.015
|
|
|
|
ventricular system development
|
GO:0021591 |
27 |
0.015
|
|
|
|
positive regulation of mitotic metaphase anaphase transition
|
GO:0045842 |
2 |
0.015
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.015
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.015
|
|
|
|
negative regulation of photoreceptor cell differentiation
|
GO:0046533 |
4 |
0.014
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.014
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.014
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.014
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.014
|
|
|
|
heart field specification
|
GO:0003128 |
6 |
0.014
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.014
|
|
|
|
homophilic cell adhesion via plasma membrane adhesion molecules
|
GO:0007156 |
18 |
0.014
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.014
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.014
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.014
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.014
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.014
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.014
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.014
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.014
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.014
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.014
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.014
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.014
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.014
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.014
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.014
|
|
|
|
glossopharyngeal nerve morphogenesis
|
GO:0021615 |
4 |
0.014
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.014
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.014
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.014
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.014
|
|
|
|
regulation of stem cell maintenance
|
GO:2000036 |
17 |
0.014
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.014
|
|
